Afatinib Afatinib

Afatinib is a targeted therapy used to treat certain types of cancer. This oral medication works by blocking specific proteins that help cancer cells grow and divide.

Afatinib is primarily used in the treatment of non-small cell lung cancer (NSCLC) and other advanced cancers. It targets mutations in the epidermal growth factor receptor (EGFR), which can drive cancer growth. Patients often wonder, 'What is Afatinib used for?' It is designed to slow or stop the progression of cancer by inhibiting these specific proteins.

Common effects of Afatinib may include skin rash, diarrhea, and fatigue. Some patients also experience nausea, loss of appetite, and dry skin. These effects can vary in severity and may require management under medical supervision.

Afatinib should be handled with care, as it is a potent medication. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. Patients should also be aware of potential interactions with other medications and should discuss their full medical history with their doctor.

Afatinib may interact with certain medications, including those that are metabolized by the liver's cytochrome P450 enzymes. Patients should avoid taking Afatinib with strong inducers or inhibitors of these enzymes. Additionally, it is important to discuss all current medications with a healthcare provider to avoid potential interactions.